The Second Affiliated Hospital Of Chongqing Medical University
Chongqing, Chongqing Municipality, 400000, China
NCT Number: NCT06553495
This study aims to compare the analgesic effect of intertransverse nerve block and paravertebral nerve block after endoscopic hepatectomy, evaluate its effectiveness and safety, and provide new ideas and clinical basis for postoperative pain management of liver surgery.
This study is active but is not currently recruiting participants.
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Chongqing, Chongqing Municipality, 400000, China
This study was a prospective, double-blind, randomized controlled trial. Patients who were eligible for laparoscopic partial liver resection in our center were included, with intertransverse nerve block as the experimental group and paravertebral nerve block as the control group. Through the analysis of postoperative pain score 30min to 24h, the number of effective analgesic pump compressions within 24h, the amount of analgesic drugs used, complications and other data, To evaluate the efficacy and safety of intertransverse nerve block in patients undergoing laparoscopic partial liver resection.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
1:
1.18-80 years old adult, BMI<27.9kg/m2
2: 2. American Society of Anesthesiologists ASA Grade I-III
3: 3. Patients with laparoscopic partial liver resection such as liver tumors
4: 4. Willing to participate in this study and sign the informed consent form
-
Exclusion criteria
-
Analgesic effect of different nerve blocks
Time frame: Within 24 hours after the operation
Jie Chen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04917796
Agnosia, CIPN - Chemotherapy-Induced Peripheral Neuropathy
Boston, Massachusetts, United States
View Trial DetailsNCT03905668
Confusion, Delirium
Gainesville, Florida, United States
View Trial DetailsNCT04385082
Abuse, Drug, Chemically-Induced Disorders
Los Angeles, California, United States
View Trial DetailsNCT07570069
Neurologic Manifestations, Pain
Salt Lake City, Utah, United States
View Trial Details